Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 90 is a member of the large family of ribonuclease P small nuclear RNA pseudogenes that share sequence similarity to the functional 7SK small nuclear RNA (RN7SK) gene. Pseudogenes like RN7SKP90 typically arise from gene duplication or retrotransposition events and are generally considered non-functional, as they do not encode an active RNA product or protein. There are over 90 RN7SK pseudogenes in the human genome, all of which lack evidence for functional RNA transcripts or a biological role. The functional RN7SK gene itself encodes a noncoding RNA component involved in regulating transcriptional elongation, but RN7SKP90 does not have this function. RN7SK pseudogene 90 (RN7SKP90) is not a therapeutic target; it is a non-functional pseudogene, has no biological function or disease role, and should not be considered for drug development or as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 90 (RN7SKP90).